Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration
Sven Magnus Hector,1 Torben Lykke Sørensen1,2 1Clinical Eye Research Unit, Zealand University Hospital, Roskilde, 2Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark Background: Individuals with neovascular age-related macular degeneration (AMD) have a...
Enregistré dans:
Auteurs principaux: | Hector SM, Sørensen TL |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a7d10b6013b34c59be8411a924746f0e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration
par: Akyol E, et autres
Publié: (2020) -
Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
par: Elfandi S, et autres
Publié: (2021) -
Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomes
par: Pedrosa AC, et autres
Publié: (2016) -
PERIPHERAL BLOOD SUBPOPULATION OF LYMPHOCYTES OF PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
par: N. V. Balatskaya, et autres
Publié: (2015) -
Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration
par: Balaratnasingam C, et autres
Publié: (2015)